Skip to content
10-K

Annual Report

BETA BIONICS, INC. BBNX

0001193125-26-067065

← back to feed
Filed
Feb 24, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2025 · Feb 20, 2026 44.38M sh
Shares Diluted FY 2025 · Dec 31, 2025 40.53M sh
Capex FY 2025 · Dec 31, 2025 $5.3M
Operating Cash Flow FY 2025 · Dec 31, 2025 −$50.93M
Short Term Investments FY 2025 · Dec 31, 2025 $187.55M
Cash And Equivalents FY 2025 · Dec 31, 2025 $31.58M
Stockholders Equity FY 2025 · Dec 31, 2025 $287.61M
Current Liabilities FY 2025 · Dec 31, 2025 $30.92M
Total Liabilities FY 2025 · Dec 31, 2025 $41.13M
Current Assets FY 2025 · Dec 31, 2025 $267.91M
Total Assets FY 2025 · Dec 31, 2025 $328.74M
Eps Diluted FY 2025 · Dec 31, 2025 −$1.81
Eps Basic FY 2025 · Dec 31, 2025 −$1.81
Sga Expense FY 2025 · Dec 31, 2025 $31.03M
Rd Expense FY 2025 · Dec 31, 2025 $34.79M
Net Income FY 2025 · Dec 31, 2025 −$73.2M
Operating Income FY 2025 · Dec 31, 2025 −$71.68M
Gross Profit FY 2025 · Dec 31, 2025 $55.54M
Cost Of Revenue FY 2025 · Dec 31, 2025 $44.71M
Revenue FY 2025 · Dec 31, 2025 $100.25M